# Globus Medical acquires Synoste

Globus Medical has acquired Synoste, a Norway-based orthopaedic bone lengthening technology spinout of Aalto University. The deal enables specialty chemicals producer Evonik to exit.

- Type: Acquisition
- Announced: 2020-10-27
- Where: Helsinki, Norway
- Status: completed
- Products: orthopaedic bone lengthening implant
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Evonik](https://endata.com/companies/15139.md) (investor)
- [Globus Medical](https://endata.com/companies/26057.md) (acquirer)
- [Synoste](https://endata.com/companies/50775.md) (target)
- [High-Tech Gründerfonds](https://endata.com/companies/50822.md) (investor)
- [Evonik Venture Capital](https://endata.com/companies/50823.md) (investor)

## Sources

- [globalventuring.com](https://globalventuring.com/university/globus-absorbs-synoste/), 2020-10-27: "Synoste, a Norway-based orthopaedic bone lengthening technology spinout of Aalto University, has been acquired by medical device manufacturer Globus Medical in a deal enabling specialty chemicals producer Evonik to exit."
- [investorsinhealthcare.com](https://www.investorsinhealthcare.com/articles/finland-globus-medical-goes-out-on-a-limb-for-synoste/), 2020-10-28: "US medical device manufacturer Globus Medical has acquired Finland's Synoste from High-Tech Gründerfonds (HTGF) and Evonik Venture Capital."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.